Why Do Indian Students Opt For Medical Education Abroad
Out of the total seats, approximately 55,000 are in government medical colleges where tuition fees are subsidised. The intense competition for these limited seats forces many high-scoring candidates to either look at costly private colleges or explore options abroad.
This trend, experts say, is driven by necessity rather than choice.
"Studying abroad can ease the academic pressure typical of the Indian medical entrance system," said a medical education consultant. "International programmes often offer multiple intakes and more flexible admission criteria, considering a student's overall academic profile, language skills, extracurricular achievements, and interview performance," Arunesh Kumar, Country Head - India & South East Asia, Manipal's American University of Antigua (AUA) College of Medicine.
Beyond accessibility, global medical universities are also attracting Indian students with modern infrastructure, integrated curricula, and early clinical exposure. Many Caribbean medical schools, for instance, combine foundational education on island campuses with clinical training in hospitals in the United States. Such programmes allow students to interact with peers from diverse nationalities and gain a global perspective essential for today's healthcare systems.
Accreditation is another factor shaping the decision. Many international medical universities are listed in the World Directory of Medical Schools (WDOMS) and are recognised by global bodies such as the World Federation for Medical Education (WFME), Educational Commission for Foreign Medical Graduates (ECFMG), and region-specific authorities like the Caribbean Accreditation Authority for Education in Medicine and other Health Professions (CAAM-HP).
These recognitions enable graduates to pursue licensure in countries such as the US, UK, and Canada, through standardised exams like USMLE or PLAB. For students seeking specialisation and a global career trajectory, international medical education offers a structured path.
"While studying medicine abroad comes with challenges such as cultural adaptation and passing foreign licensing exams, it remains a strategic option," the consultant added. "For those unable to secure domestic seats or those aiming for global careers, it's not a fallback - it's a forward-looking decision."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Max, Aster DM, Apollo rally up to 7%; what's driving hospital stocks today?
Hospital stocks in focus: Shares of the listed companies engaged in hospital business like Max Healthcare Institute, Aster DM Healthcare and Apollo Hospitals Enterprise have rallied up to 7 per cent, hitting their respective new highs on the BSE in Thursday's intra-day trade on healthy business outlook. Among the individual stocks, Aster DM Healthcare has surged 7 per cent to ₹638.60, on the back of a 20-fold jump in average trading volumes. A combined 16.06 million equity shares representing 3.2 per cent of total equity of the company have changed hands on the NSE and BSE. Shares of Apollo Hospitals Enterprise (₹7,599.75) and Max Healthcare Institute (₹1,308.55) were up 2 per cent on the BSE. Besides these three stocks, Global Health, Fortis Healthcare, Fortis Malar Hospitals, Narayana Hrudayalaya and Yatharth Hospital & Trauma Care Services were up in the range of 1 per cent to 3 per cent. In comparison, the BSE Sensex was up 0.18 per cent at 83,562 at 02:07 PM. What's driving hospital stocks? According to CRISIL MI&A Research, the Indian healthcare delivery industry is projected to experience major growth, with a compound annual growth rate (CAGR) of 9-11 per cent anticipated between fiscal years 2025 and 2027. This growth trajectory is underpinned by several long term structural factors, including rising healthcare needs due to demographic shifts and increasing chronic disease prevalence. Additionally, the industry's strong fundamentals, coupled with improving affordability among the population, are expected to drive demand for healthcare services. Furthermore, the potential impact of initiatives such as the Ayushman Bharat scheme, aimed at providing universal health coverage, is poised to further propel industry growth during this period. With sustained support from long-term structural factors, renewed emphasis on the Pradhan Mantri Jan Arogya Yojana (PMJAY), and heightened Government focus on the healthcare sector, the healthcare delivery market is projected to expand at a CAGR of approximately 9-11 per cent, reaching ₹8.6 trillion by fiscal 2027, Apollo Hospital said in its annual report. Given the major mismatch between demand and supply for quality beds, along with the improved financial health of corporate hospitals following the pandemic, players appear well-positioned to achieve profitable growth as they strengthen their presence in core markets and venture into Tier 2+ areas geographies, CareEdge Ratings said. CareEdge Ratings forecasts that the corporate hospital chains in its coverage will achieve approximately 10-12 per cent year-on-year sales growth in fiscal 2026, driven by a 5-6 per cent increase in Average Revenue Per Occupied Bed (ARPOB), a 100-200 basis point (bps) improvement in occupancy, and rise in new bed additions. With significant untapped market opportunities and a shortage of healthcare infrastructure in India, leading Indian companies have immense potential for expansion. Supported by long-term structural growth factors, renewed momentum from PMJAY, and increased government focus on the healthcare sector, the Indian hospital sector is projected to grow at a CAGR of 10-11 per cent over the next 3-5 years. Key demand drivers include the rise in lifestyle-related diseases, growing medical tourism, increasing incomes, and demographic changes. With limited government capital expenditure and a lack of infrastructure, the private sector is expected to experience accelerated growth in the years to come, CareEdge Ratings said in its March 2025 report.
Time of India
2 hours ago
- Time of India
Smart Dialysis Ecosystems: Next Generation Precision Care Using AI
India is facing a silent yet significant kidney care crisis. With over 220,000 new end-stage renal disease (ESRD) patients added every year, the need for 34 million dialysis treatments is created, and the supply-demand gap continues to widen. Today, the country has barely 50,000 dialysis machines to serve a population that requires more than double that number. Almost 60% of patients are forced to travel more than 50 km per session, resulting in dropouts, delayed treatment, and potentially avoidable complications. What India needs is not only a greater number of such centers, but also smarter and interconnected dialysis ecosystems enhanced by the power of artificial intelligence, machine learning, and IoT. These new-age technologies are establishing the foundation of precision care in nephrology . The Artificial Intelligence Revolution in Kidney Care Predictive analytics is the driving force of this evolution. Artificial intelligence models can currently process real-time data on blood pressure trends, fluid levels, and treatment history to predict complications like intradialytic hypotension with more than 90% accuracy. Such proactive monitoring reduces the need for emergency interventions and enhances patient safety on a larger scale. What's more, personalized treatment plans, once an elite hospital's privilege, are becoming scalable. Adjusting the duration of dialysis, rates of fluid removal, and doses of medication according to individual patient profiles gives rise to the concept of machine learning. This results in significantly better outcomes, 20 to 30% better, and allows patients to lead more complete lives despite living with a chronic disease. Reducing the Urban-Rural Divide With Remote Monitoring The fact on the ground is plain: most dialysis centres are based in the cities. But now, with monitoring-capable dialysis machines and the Internet of Things, nephrologists can remotely monitor sessions at rural and semi-urban centres. This both enhances quality control and saves on patient travel time and dropout rates. Operationally, Artificial Intelligence is increasing efficiency as well, through automated scheduling, inventory management, and predictive maintenance for machines. These advancements result in reduced costs, decreased absence of usage sessions, and greater dependability—all key factors in a resource-limited healthcare environment. Creating an Ecosystem: Policy, Partnerships and Purpose It's crucial that dialysis care doesn't progress in isolated silos. Public-private partnerships (PPPs) like the ones envisioned by the Pradhan Mantri National Dialysis Program are essential for scaling up smart dialysis solutions. The Indian government has emphasized indigenous manufacturing and digital health, paving the way for Artificial Intelligence to become a mainstream part of healthcare delivery. Sustainability is another key benefit. Smart dialysis centres are more conservative about water and power use, and they are less wasteful in their approach. Predictive tools help prevent machine downtime, making it viable even in the most remote or under-resourced parts of the country. A Glimpse into the Future Artificial Intelligence is not the end; it's the beginning and the enabler behind achieving quality dialysis equity for all. As we now move into the age of 3D-printed organs, AI-augmented artificial kidneys, and real-time biomarker monitoring, our vision at NephroPlus extends beyond treatment. Our zero-cost Hepatitis C elimination program across Bihar and Andhra Pradesh has screened and treated hundreds of dialysis patients, showcasing the power of data-driven, integrated, and patient-first care. On top of that, NephroPlus uses data-driven insights to enhance patient care by spotting trends and refining treatment plans. This enables us to tailor our services to meet each patient's unique needs more effectively. India is well-positioned to become the global leader in smart dialysis care, not by emulating the Western model but by creating smart, scalable, and sustainable systems that fit our ground realities. This article is written by Vikram Vuppala Founder and CEO, NephroPlus Disclaimer - The above content is non-editorial, and ET Healthworld hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content.
Time of India
2 hours ago
- Time of India
Benefits of jamun seed powder: The Ayurvedic superfood that may help control diabetes naturally
Diabetes is an increasingly widespread health issue, and many are seeking natural solutions to accompany conventional treatment. One such ancient remedy that is seeing increased popularity in contemporary times is jamun seed powder. Extracted from seeds of the Indian blackberry (Syzygium cumini), this plant supplement has been applied in Ayurvedic medicine for centuries as an aid to blood sugar control. Rich in jamboline and jambosine compounds, jamun seed powder might enhance insulin sensitivity, prevent sugar uptake, and promote overall metabolic function. Never a replacement for prescribed medication, but a useful addition to a diabetes-promoting lifestyle when used under proper supervision. A useful component of a preventive plan is when combined with proper diet, exercise, and regular medical checkups. What makes jamun seed powder effective Jamun seed powder has been employed traditionally for centuries as a medicine to control digestive problems and diabetes. Its effectiveness is owed to two bioactive molecules: Jamboline : Retards the conversion of starch to sugar in the gut, thus avoiding sudden increases in blood glucose levels post-meals. Jambosine : Increases the body's sensitivity to insulin and aids the pancreas to produce it more effectively. Antioxidant and anti-Inflammatory activities: Aside from glucose management, jamun seed powder is a natural antioxidant. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 3.5, 4.5 BHK Homes starting at ₹4.89 Cr.* Hero Homes Learn More Undo It fights oxidative stress, it reduces inflammation, and safeguards critical organs like the liver and kidneys—organs usually taxed in individuals with chronic diabetes. Source: Amazon Benefits of jamun seed powder to individuals with diabetes Enhances sensitivity to insulin One of the key advantages is that jamun seed powder improves the efficiency of insulin. This causes the body to be able to use glucose more efficiently and assists in lowering insulin resistance, a major cause of Type 2 diabetes. Controls post-meal sugar spikes By inhibiting carbohydrate metabolism, the powder decreases the rapid peak in blood sugar that typically occurs after eating—especially beneficial for individuals who experience postprandial hyperglycemia. Supports pancreatic health Certain studies indicate that chemicals present in jamun seeds could aid the regeneration of beta cells in the pancreas, which are in charge of insulin release. Shields liver and kidneys Diabetes can gradually damage the liver and kidneys. Jamun seed powder has antioxidant action that shields these organs from oxidative damage and inflammation. Could decrease in diabetic complications By enhancing metabolic equilibrium, jamun seed powder can potentially lower the risk of complications like neuropathy, nephropathy, and diabetic retinopathy. How to consume jamun seed powder The commonly advised dose is 1 to 2 teaspoons daily. Yet, it's advisable to consult a doctor to find out what suits you. Ways of using it: Combined with warm water: Common Ayurvedic method, particularly when taken prior to meals. Sprinkled on food: May be sprinkled on smoothies, yogurt, or salads. Capsule form: Suitable for patients who do not like the taste of the powder being too bitter. When to have jamun seed powder Before or during meals: Assists in regulating sugar absorption after meals. Empty stomach (optional): A few practitioners recommend this for better absorption and digestive benefits. Risks and side effects of consuming jamun seed powder Although jamun seed powder is reportedly safe for the majority of individuals, it can create some dangers if used inappropriately—particularly for those already on blood sugar-controlling medication. Potential side effects: Hypoglycemia: When taken with insulin or anti-diabetic medication, there is a risk of causing dangerously low blood sugar. Constipation: The digestive system may be affected by some users. Allergic reactions: Though rare, may occur in sensitive individuals. Drug interactions: May interact with oral hypoglycemic agents or injections of insulin. * Tip: Pregnant and lactating women, and people with kidney disease, must consult a doctor before taking this supplement. Short- and long-term impact of consuming jamun seed powder Short-term impact (2–4 weeks) Enhanced control of blood glucose levels Less hunger for sweet food Increased energy and concentration Long-term advantages (8–12 weeks) Decrease in HbA1c (a reflection of long-term blood sugar control) Potential improvement in insulin secretion and organ function Should you add jamun seed powder to your regimen Jamun seed powder is a cheap, available, and well-studied herbal remedy that has very promising benefits for managing blood sugar levels. That said, it must not be used as an alternative medicine or in place of diabetes medication. Also Read | What is oral cancer: Know its symptoms, causes, and why early detection may save your life
